{"prompt": "['PREDM', 'Page 25', 'Barriers and facilitators to medication adherence will be assessed at 24-week', 'visit using a modified version of the PETIT questionnaire (Appendix VI)', 'Barriers and facilitators to participation will be assessed at 24-week visit using a', 'questionnaire developed from previously identified categories of barriers to', 'participation in healthy behavior change (Appendix VI)', '5.0 TREATMENT PLAN', '5.1 Treatment', 'Eligible subjects who meet inclusion criteria will be enrolled on study at', 'Screening/Day 0. Study assessments included in the SJLIFE Core visit and study', 'specific laboratory assessments will be completed at the screening visit including', 'body fat percentage using skin calipers, abdominal circumference, hip circumference,', 'SF-36 vitality subscale, walking speed and hand grip strength. Participants will be', 'given a test dose of metformin ER (500 mg) and monitored for any adverse effects', 'of medication for 1 hour in clinic by the study team. The dose will be administered', 'after a meal or snack. At the study visit they will be dispensed the study drug and', 'enrolled on the digital lifestyle 5.2 change program. A username will be selected by', 'the study participant with the option to choose from a number of study team generated', 'user names to provide anonymity for the study participant during group sessions.', 'On Day 1, participants will begin their digital lifestyle intervention using their smart-', 'phone application with their lifestyle coach and peer group. On the same day, they', 'will also begin metformin ER 500 mg daily for 14 days, taken after the evening meal.', 'The 14-day supply will include additional tablets to prevent days off medication', 'while titration occurs. Day 1 will occur at least 7 days (to allow for baseline physical', 'activity data collection) and up to 28 days after screening assessments and', 'participants will be notified of the start date based on assignment to a lifestyle', 'intervention group.', 'On day 14, participants will be contacted by phone (+/- 4 days, day 10 to 18) and', 'adherence assessed using virtual pill counts via phone calls, the protocol will be', 'adapted from Kalichman et al.39, and symptoms assessed using the Global Rating of', 'Side Effects Burden (Appendix II), which includes the CTCAE v5.0 grading of', 'events. After this call, if there are no signs or symptoms of adverse events, metformin', 'ER dose will be increased to 1000 mg daily and mailed to participant.', 'At weeks 4, 8, 16 and 20 a phone-based pill count for adherence and adverse event', 'symptom log will be completed and study medication dispensed.', 'At week 12 (interim assessment) and 24 (study-end), the participant will return to St.', \"Jude Children's Research Hospital (SJCRH) for an in-person assessment to include\", \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date 00-00-00', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']['PREDM', 'Page 26', 'history and physical examination (weight, BMI, blood pressure, anthropometric', 'measures, walking speed (week 24 only), hand-grip strength (week 24 only)), fasting', 'blood work (FPG, HbA1c, insulin, IGFBP-1, CMP, CBC, lactate, cystatin C, lipid', 'panel, pregnancy test if appropriate), adherence assessment by pill-count (all', 'medication dispensed from past 12 weeks will be assessed to monitor for adherence', 'over the prior 4 weeks and verify virtual assessments), NHANES-PAQ for self-', 'reported physical activity, SF-36 for HRQOL and frailty measure of exhaustion', 'which uses the vitality subscale, and CTCAE for adverse event grading will be', 'completed. Accelerometer will be mailed at least 10 days prior to the on campus visit', 'for collection of physical activity data.', 'The digital lifestyle change program will complete at week 24. We will collect data', 'on lesson completion, self-reported weight, food logging, activity logging,', 'participation with coach messages, participation with peer groups, dates and', 'frequency of app access, and time spent in application.', 'The lifestyle change program includes dietary change with a goal to target 5%', 'weight loss (among participants with a BMI >22 kg/m\u00b2) and at least 150 min/wk.', 'moderate intensity physical activity (brisk walking, biking, swimming, etc.) using a', 'digital, app-based platform that includes a lifestyle coach who helps facilitate a', 'core-curriculum focused on diet, exercise and behavioral strategies for goal setting', 'and self-monitoring. Weight loss in this pilot would be a goal for participants with', 'BMI >22 kg/m\u00b2; however, dietary change, increased lean muscle mass and', 'increased physical activity are desirable for all survivors. Participants will complete', 'the remote, digitally-delivered core-curriculum, over 24 weeks with adherence', 'measured by completion logs as well as monitoring of physical activity both by', 'self-report (NHANES-PAQ) and accelerometer data.', '5.2 Dose Modifications', 'All patients will be assessed throughout the 24 weeks of the study with assessment', 'at weeks 2, 4, 8, 12, 16, 20 and 24 time-points. If a severe adverse event occurs at', 'any time, a formal review will occur.', 'It is the responsibility of the Principal Investigator to oversee the safety of the', 'study. This safety monitoring will include careful assessment and appropriate', 'reporting of adverse events as noted below, as well as implementation of data and', 'safety-monitoring. Medical monitoring will include a regular assessment of the', 'number and type of serious adverse events.', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date 00-00-00', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}